Shasun Pharmaceuticals Ltd.
NSE: SHASUNPHAR | BSE: 524552
₹428.55
₹21.95
(5.40%)
As on 17-Nov-2015IST
Market cap
₹2,884 Cr
Revenue (TTM)
₹1,074 Cr
P/E Ratio
63.8
P/B Ratio
6
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹24 Cr
-
ROE
7.3 %
-
ROCE
8.8 %
-
Industry P/E
46.93
-
EV/EBITDA
23.7
-
Debt to Equity
1.5
-
Book Value
₹--
-
EPS
₹--
-
Face value
2
-
Shares outstanding
67,255,452
10 Years Aggregate
CFO
₹354.68 Cr
EBITDA
₹650.74 Cr
Net Profit
₹214.94 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shasun Pharma
| 50.2 | 8.8 | 8.5 | 103.1 | 40.1 | 43.1 | 18.3 |
|
BSE Sensex*
| -10.4 | -1.0 | -7.8 | -7.7 | 6.7 | 8.3 | 11.1 |
|
BSE Healthcare#
| 9.3 | 8.8 | 6.8 | 11.3 | 26.4 | 14.0 | 12.1 |
|
Company
|
2014
|
|---|---|
|
Shasun Pharma
| 221.0 |
|
BSE Sensex
| 29.9 |
|
BSE Healthcare
| 47.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Shasun Pharma
|
428.6 | 2,884.3 | 1,074.4 | 44.7 | 7.6 | 10.3 | 63.8 | 6.0 |
| 3,000.6 | 24,577.7 | 1,339.4 | 356.4 | 33.2 | 23.2 | 69 | 14.9 | |
| 428.8 | 16,406.4 | 2,268.6 | 150.1 | 10.6 | 5.4 | 91.5 | 4.2 | |
| 782.6 | 19,421.1 | 5,365.6 | 595.0 | 16.6 | 13.3 | 32.6 | 3.8 | |
| 991.8 | 15,788.7 | 8,279.6 | 397.8 | 9.9 | 6.4 | 39.6 | 2.2 | |
| 1,175.8 | 21,056.2 | 4,560.2 | 1,544.6 | 35.1 | 19.2 | 13.5 | 2.4 | |
| 1,791.1 | 20,554.3 | 1,421.6 | -73.8 | 1.8 | -1.1 | -- | 3.5 | |
| 174.2 | 23,155.5 | 8,869.1 | -383.1 | 1.0 | -4.2 | -- | 2.8 | |
| 460.4 | 18,574.8 | 3,738.7 | 316.7 | 12.5 | 7.5 | 58.7 | 3.8 | |
| 1,771.0 | 28,787.9 | 3,373.0 | 199.0 | 12.6 | 5.9 | 135.2 | 5.8 |
Shareholding Pattern
View DetailsNews & Analysis
All News
Sensex: The index which wouldn't grow up
2 min read•By Vikas Vardhan
About Shasun Pharma
Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable... alkaloids; Read more
-
Incorporated
1976
-
Chairman
R Kannan
-
Managing Director
S Abhaya Kumar
-
Headquarters
Chennai, Tamil Nadu
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsRecord Date for Scheme of Amalgamation
06-Nov-2015Shareholding Pattern for September 30, 2015
13-Oct-2015No News & Announcements are available.
FAQs for Shasun Pharma
What is the current share price of Shasun Pharmaceuticals Ltd Today?
The share price of Shasun Pharmaceuticals Ltd is ₹428.55 (NSE) and ₹428.85 (BSE) as of 17-Nov-2015 IST. Shasun Pharmaceuticals Ltd has given a return of 40.14% in the last 3 years.
What is the current PB & PE ratio of Shasun Pharmaceuticals Ltd?
The P/E ratio of Shasun Pharmaceuticals Ltd is 63.83 times as on 17-Nov-2015, a 36 premium to its peers’ median range of 46.93 times.
The P/B ratio of Shasun Pharmaceuticals Ltd is 5.99 times as on 17-Nov-2015, a 54 premium to its peers’ median range of 3.88 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2015
|
93.92
|
6.25
|
|
2014
|
13.26
|
1.33
|
|
2013
|
7.14
|
1.41
|
|
2012
|
4.58
|
2.11
|
|
2011
|
9.47
|
3.02
|
What is the 52 Week High and Low of Shasun Pharmaceuticals Ltd?
The 52-week high and low of Shasun Pharmaceuticals Ltd are Rs -- and Rs -- as of 27-May-2026.
What is the market cap of Shasun Pharmaceuticals Ltd?
Shasun Pharmaceuticals Ltd has a market capitalisation of ₹ 2,884 Cr as on 17-Nov-2015. As per SEBI classification, it is a company.
Should I invest in Shasun Pharmaceuticals Ltd?
Before investing in Shasun Pharmaceuticals Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.